Does NITRAZEPAM Cause Disseminated intravascular coagulation? 14 Reports in FDA Database
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Disseminated intravascular coagulation have been filed in association with NITRAZEPAM. This represents 1.2% of all adverse event reports for NITRAZEPAM.
14
Reports of Disseminated intravascular coagulation with NITRAZEPAM
1.2%
of all NITRAZEPAM reports
13
Deaths
12
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From NITRAZEPAM?
Of the 14 reports, 13 (92.9%) resulted in death, 12 (85.7%) required hospitalization.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITRAZEPAM. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does NITRAZEPAM Cause?
Toxicity to various agents (228)
Suicide attempt (105)
Chest discomfort (102)
Intentional overdose (102)
Drug ineffective (101)
Fall (95)
Somnolence (93)
Drug abuse (86)
Overdose (74)
Off label use (70)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which NITRAZEPAM Alternatives Have Lower Disseminated intravascular coagulation Risk?
NITRAZEPAM vs NITRENDIPINE
NITRAZEPAM vs NITRIC
NITRAZEPAM vs NITROFURANTOIN
NITRAZEPAM vs NITROFURANTOIN\NITROFURANTOIN
NITRAZEPAM vs NITROFURAZONE